MA04.02 Lung Cancer Screening Utilization and Its Correlates in Sexual Minorities: An Analysis of the BRFSS 2018

Xie, Hui; Li, Yannan; Wang, Q.; Fujiwara, Yu; Kurbanova, Tamara; Theodoropoulos, Nicholas

doi:10.1016/j.jtho.2021.01.224

Cited by 2 publications

(1 citation statement)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Although there are other risk factors for developing lung cancer, the high incidence of smoking within the LGBTQIA+ populations warrants education on smoking cessation and lung cancer screening. In one study, males who self-identified as gay/lesbian and who had no medical cost burden had higher odds of receiving lung cancer screening, whereas being bisexual was associated with a lower likelihood of screening, suggesting there are sexual-identity disparities in utilizing lung cancer screening ( 94 ). After diagnosis, treatment options for gender minority individuals appeared to have similar proportions of surgical, chemotherapy, and radiation therapies as gender majority ( 95 ).…”

Section: Ruralmentioning

confidence: 99%

Health inequities across the lung cancer care continuum in ten marginalized populations: a narrative review

Monestime,

Rigney,

Phipps

et al. 2023

J Thorac Dis

View full text Add to dashboard Cite

Background and Objective Lung cancer remains the deadliest cancer in the United States. Although lung cancer screening and innovative treatment options are available, accessing these interventions remains a barrier for marginalized communities due to social and structural challenges that influence health care access, which has led to worse outcomes when compared to Non-Hispanic Whites (NHW) and non-marginalized populations. The objective of this study is to examine disparities in lung cancer and social/structural factors within ten critical populations (racial/ethnic minorities, low income, rural, LGBTQIA+, women, veteran and active duty, and small cell lung cancer) across the continuum of lung cancer care. Methods Five databases (PubMed, the Cochrane Library, EMBASE, Web of Knowledge, and EBSCO Discovery Service) were queried from February 2022–June 2022. The inclusion criteria were (I) peer-reviewed academic journals published in English between the years 2000 and 2022; (II) research that focused on disparities across the lung cancer continuum; and (III) research articles addressing social and structural barriers to lung cancer health care access. A total of 95 articles and 24 reports were used for this narrative review. Key Content and Findings Across the ten populations, consistent disparities were observed in lung cancer screening and treatment, exhibited by lower uptake in screening, treatment, clinical trials, and biomarker testing. Significant themes contributing to these disparities were socioeconomic status, transportation, language, historic trauma, provider bias or lack of cultural training, and lack of health care access, in part due to insurance coverage. Conclusions Future studies are needed to further develop meaningful solutions to disparities in health outcomes and access for those who are at risk, diagnosed with, or surviving lung cancer from marginalized populations.

show abstract

Section: Ruralmentioning

confidence: 99%